1.236 artigos
Jupiter Neurosciences launches a 30-patient trial of JOTROL, a high-bioavailability resveratrol formula targeting Parkinson's disease.
NeuroXT and BIDMC expand their AI-driven imaging partnership to assess whether MRI-based biomarkers can guide personalized Alzheimer's therapy.
As wearables track hormones, blood pressure, and heart rhythm, regulators are drawing new lines health-tech users need to understand.
Protuoso Biosciences raises $9.5M to build AI-engineered therapies that tackle multiple disease mechanisms simultaneously in one molecule.
A multimillion-dollar AI collaboration aims to predict cancer, heart disease, and neurodegeneration years before symptoms appear.
New mouse research finds the trendy D+Q senolytic combo severely damages myelin, raising red flags for longevity self-experimenters.
A small trial found tocilizumab, an anti-inflammatory drug, cut depression remission rates better than SSRIs by targeting IL-6, not brain chemistry.
A UC San Diego trial shows ION224 blocks liver fat production, cutting inflammation and scarring in 60% of MASH patients.
A review of 17 studies finds guava juice paired with iron supplements raises hemoglobin by 1.29 g/dl more than supplements alone.
Scientists mapped a two-pathway gut-brain alarm that shifts appetite from sugar to protein when essential amino acids drop.
Updated American Cancer Society guidelines endorse blood-based colorectal cancer tests as an alternative for adults who decline colonoscopy or stool tests.
A randomized trial found hypothermic oxygenated perfusion slashed early graft failure rates from 37% to 20% in liver transplant patients.
